C3H apoE(-/-) mice have less atherosclerosis than C57BL apoE(-/-) mice despite having a more atherogenic serum lipid profile

Atherosclerosis

Volumn 151, Issue 2, 2000, Pages 389-397

  Grimsditch, D C ^a   Penfold, S ^a   Latcham, J ^a   Vidgeon Hart, M ^a   Groot, P H E ^a   Benson, G M ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Atherosclerosis; C3H; C57BL; Female; Lesion area; Male; Western diet

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; CHYLOMICRON; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LESION; ARTICLE; ATHEROGENESIS; ATHEROGENIC DIET; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FAT INTAKE; FEMALE; GENETIC PREDISPOSITION; HYPERLIPOPROTEINEMIA TYPE 3; LIPOPROTEIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; STRAIN DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; BODY WEIGHT; CHOLESTEROL; DIET, ATHEROGENIC; EATING; FEMALE; LIPID METABOLISM; LIPIDS; LIPOPROTEINS; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; OSMOLAR CONCENTRATION; SEX CHARACTERISTICS; SPECIES SPECIFICITY; TRIGLYCERIDES;

EID: 0033863249     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00400-1     Document Type: Article

References (24)

1. Paigen B., Ishida B.Y., Verstuyft J., Winters R.B., Albee D. Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. Arteriosclerosis. 10:1990;316-323.
2. Nishina P.M., Wang J., Toyofuku W., Kuypers F.A., Ishida B.Y., Paigen B. Atherosclerosis and plasma and liver lipids in nine inbred strains of mice. Lipids. 28:1993;599-605.
3. Ishii I., Ito Y., Morisaki N., Saito Y., Hirose S. Genetic differences of lipid metabolism in macrophages from C57BL/6J and C3H/HeN mice. Arterioscler. Thromb. Vasc. Biol. 15:1995;1189-1194.
4. Paigen B. Genetics of responsiveness to high-fat and high-cholesterol diets in the mouse. Am. J. Clin. Nutr. 62:1995;458S-462S.
5. Hofker M.H., van Vlijmen B.J., Havekes L.M. Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosis. Atherosclerosis. 137:1998;1-11.
6. Plump A.S., Smith J.D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J.G., Rubin E.M. et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:1992;343-353.
7. Piedrahita J.A., Zhang S.H., Hagaman J.R., Oliver P.M., Maeda N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Nat. Acad. Sci. USA. 89:1992;4471-4475.
8. Zhang S.H., Reddick R.L., Piedrahita J.A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258:1992;468-471.
9. Nakashima Y., Plump A.S., Raines E.W., Breslow J.L., Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14:1994;133-140.
10. Paigen B., Holmes P.A., Mitchell D., Albee D. Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL/6, BALB/c, and C3H. Atherosclerosis. 64:1987;215-221.
11. Nishina P.M., Verstuyft J., Paigen B. Synthetic low and high fat diets for the study of atherosclerosis in the mouse. J. Lipid Res. 31:1990;859-869.
12. Hennes U., Gross W., Edelmann A. Changes of lipoprotein patterns in hamsters under different metabolic states analyzed following separation by micropreparative chromatography on SMART™ System from multiple micro plasma samplings. Sci. Tools. 36:1992;10-12.
13. Paigen B., Morrow A., Holmes P.A., Mitchell D., Williams R.A. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 68:1987;231-240.
14. Groot P.H., van Vlijmen B.J., Benson G.M., Hofker M.H., Schiffelers R., Vidgeon-Hart M. et al. Quantitative assessment of aortic atherosclerosis in APOE*3 Leiden transgenic mice and its relationship to serum cholesterol exposure. Arterioscler. Thromb. Vasc. Biol. 16:1996;926-933.
15. Paigen B., Morrow A., Brandon C., Mitchell D., Holmes P. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis. 57:1985;65-73.
16. Tangirala R.K., Casanada F., Miller E., Witztum J.L., Steinberg D., Palinski W. Effect of the antioxidant N,N′-diphenyl 1,4-phenylenediamine (DPPD) on atherosclerosis in apoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 15:1995;1625-1630.
17. Qiao J.H., Xie P.Z., Fishbein M.C., Kreuzer J., Drake T.A., Demer L.L. et al. Pathology of atheromatous lesions in inbred and genetically engineered mice: genetic determination of arterial calcification. Arterioscler. Thromb. 14:1994;1480-1497.
18. Ishibashi S., Herz J., Maeda N., Goldstein J.L., Brown M.S. The two-receptor model of lipoprotein clearance: tests of the hypothesis in 'knockout' mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc. Nat. Acad. Sci. USA. 91:1994;4431-4435.
19. Assmann G Lipid Metabolism Disorders and Coronary Heart Disease. 1993;98 MMV Medizin Verlag GmbH, München.
20. Renier G., Skamene E., DeSanctis J.B., Radzioch D. High macrophage lipoprotein lipase expression and secretion are associated in inbred murine strains with susceptibility to atherosclerosis. Arterioscler. Thromb. 13:1993;190-196.
21. Shih D.M., Welch C., Lusis A.J. New insights into atherosclerosis from studies with mouse models. Mol. Med. Today. 1:1995;364-372.
22. Hayek T., Oiknine J., Dankner G., Brook J.G., Aviram M. HDL apolipoprotein A-I attenuates oxidative modification of low density lipoprotein-studies in transgenic mice. Eur. J. Clin. Chem. Clin. Biochem. 33:1995;721-725.
23. Breslow J.L. Mouse models of atherosclerosis. Science. 272:1996;685-688.
24. Ishida B.Y., Blanche P.J., Nichols A.V., Yashar M., Paigen B. Effects of atherogenic diet consumption on lipoproteins in mouse strains C57BL/6 and C3H. J. Lipid Res. 32:1991;559-568.